In-Stent Restenosis

What is In-Stent Restenosis?

In-Stent Restenosis (ISR) refers to the recurrence of narrowing or blockage within a previously implanted stent, a small mesh tube used to keep arteries open. This condition typically occurs after a patient has undergone a stenting procedure to treat coronary artery disease or peripheral vascular disease. Despite the initial success of stent placement, ISR can develop over time, leading to symptoms and potentially complicating the patient's recovery.

Side effects of In-Stent Restenosis:

The development of ISR can result in various symptoms, including chest pain (angina), shortness of breath, fatigue, and even heart attack or stroke if left untreated. These symptoms may significantly impact a patient's quality of life and require prompt medical attention to prevent further complications.

How is In-Stent Restenosis diagnosed?

Diagnosing In-Stent Restenosis often involves a combination of clinical evaluation, imaging tests, and possibly cardiac catheterization.

Your healthcare provider may perform tests such as angiography, intravascular ultrasound (IVUS), or optical coherence tomography (OCT) to assess the extent of narrowing within the stented artery.

These diagnostic procedures help determine the severity of ISR and guide treatment decisions.

Potential treatments of In-Stent Restenosis:

The management of ISR typically involves a multidisciplinary approach tailored to the individual patient's needs. Treatment options may include:

• Medications: Your doctor may prescribe medications to help manage symptoms and reduce the risk of further complications. These may include antiplatelet agents, statins, and other medications to control blood pressure and cholesterol levels.

• Percutaneous Coronary Intervention (PCI): In cases where ISR is causing significant narrowing of the artery, a repeat stenting procedure, known as a "stent-in-stent" procedure, may be performed to reopen the blocked artery and restore blood flow. This minimally invasive procedure is typically conducted by an interventional cardiologist in a catheterization lab.

• Drug-Coated Balloons (DCB) or Drug-Eluting Stents (DES): These advanced technologies involve the use of stents or balloons coated with medications that help prevent the recurrence of restenosis. DCB or DES may be recommended in certain cases to improve long-term outcomes and reduce the risk of ISR recurrence.

• Coronary Artery Bypass Grafting (CABG): In more complex cases of ISR or when other treatment options are not feasible, coronary artery bypass surgery may be considered. This surgical procedure involves creating new routes for blood flow around the blocked or narrowed arteries using grafts from other parts of the body.

👉 Contact us for further information and receive acomplimentary consultation.